Tobacco Settlement Endowment Trust Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.
Department of Family and Preventive Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Cancer. 2023 Nov 1;129(21):3498-3508. doi: 10.1002/cncr.34922. Epub 2023 Jun 24.
Little is known about the risks and benefits of cannabis use in the context of cancer care. This study characterized the prevalence, reasons for use, and perceived benefits of cannabis and compared symptoms and perceived risks between those who reported past 30-day cannabis use and those who did not.
Adults undergoing cancer treatment at a National Cancer Institute-designated cancer center completed measures of sociodemographic characteristics, cannabis use, use modalities, reasons for use, perceived harms/benefits of use, physical and psychological symptoms, and other substance/medication use. Analyses compared patients who used or did not use cannabis in the past 30 days.
Participants (N = 267) were 58 years old on average, primarily female (70%), and predominantly White (88%). Over a quarter of respondents (26%) reported past 30-day cannabis use, and among those, 4.5% screened positive for cannabis use disorder. Participants who used cannabis most often used edibles (65%) or smoked cannabis (51%), and they were younger and more likely to be male, Black, and disabled, and to have lower income and Medicaid insurance than participants who did not use cannabis. Those who used cannabis reported more severe symptoms and perceived cannabis as less harmful than those who did not use cannabis. The most common medical reasons for cannabis use were pain, cancer, sleep problems, anxiety, nausea/vomiting, and poor appetite. Participants reported the greatest cannabis-related symptom relief from sleep problems, nausea/vomiting, headaches, pain, muscle spasms, and anxiety.
Patients with cancer who used cannabis perceived benefits for many symptoms, although they showed worse overall symptomatology.
Among adults undergoing cancer treatment, 26% reported cannabis use in the past 30 days. Those who used cannabis were more likely to be male and disabled and to have lower income and Medicaid insurance than those who did not use cannabis. Participants most commonly reported using cannabis for pain, cancer, sleep, anxiety, and nausea/vomiting and reported the greatest perceived benefits for sleep, nausea/vomiting, headaches, pain, muscle spasms, and anxiety, yet participants who used cannabis also reported feeling worse physically and psychologically compared to those who did not use cannabis. Participants who used cannabis were more likely to report that cannabis was less risky to their health than alcohol, smoking, and opioids than those who did not use cannabis.
在癌症治疗背景下,人们对大麻使用的风险和益处知之甚少。本研究描述了大麻的使用频率、使用原因和感知益处,并比较了过去 30 天内使用大麻和未使用大麻的患者的症状和感知风险。
在一家美国国立癌症研究所指定的癌症中心接受癌症治疗的成年人完成了社会人口特征、大麻使用、使用方式、使用原因、使用的感知危害/益处、身体和心理症状以及其他物质/药物使用的测量。分析比较了过去 30 天内使用或未使用大麻的患者。
参与者(N=267)的平均年龄为 58 岁,主要为女性(70%),绝大多数为白人(88%)。超过四分之一的受访者(26%)报告过去 30 天内使用过大麻,其中 4.5%的人大麻使用障碍筛查呈阳性。过去 30 天内使用大麻的参与者最常使用的是大麻食品(65%)或吸食大麻(51%),他们更年轻,更有可能是男性、黑人、残疾,收入较低,且拥有医疗补助保险,而不使用大麻的参与者则没有这些特征。使用大麻的参与者报告的症状更严重,且他们认为大麻的危害较小。使用大麻最常见的医学原因是疼痛、癌症、睡眠问题、焦虑、恶心/呕吐和食欲不振。参与者报告称,使用大麻最能缓解睡眠问题、恶心/呕吐、头痛、疼痛、肌肉痉挛和焦虑。
在接受癌症治疗的患者中,有 26%的人在过去 30 天内使用过大麻,他们对许多症状的治疗效果较好,尽管他们的整体症状更严重。